These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 16733740
1. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. Bernardini S, Nuccetelli M, Noguera NI, Bellincampi L, Lunghi P, Bonati A, Mann K, Miller WH, Federici G, Lo Coco F. Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740 [Abstract] [Full Text] [Related]
2. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN. Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664 [Abstract] [Full Text] [Related]
3. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28). Giri U, Terry NH, Kala SV, Lieberman MW, Story MD. Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769 [Abstract] [Full Text] [Related]
4. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B, Yang X, An L, Gao B, Liu X. Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005 [Abstract] [Full Text] [Related]
5. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [Abstract] [Full Text] [Related]
6. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia. Sahu GR, Jena RK. Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419 [Abstract] [Full Text] [Related]
7. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells. Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X. Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431 [Abstract] [Full Text] [Related]
8. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1. Chelbi-alix MK, Bobé P, Benoit G, Canova A, Pine R. Oncogene; 2003 Dec 11; 22(57):9121-30. PubMed ID: 14668793 [Abstract] [Full Text] [Related]
9. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. Zhu J, Okumura H, Ohtake S, Nakamura S, Nakao S. Oncol Rep; 2003 Dec 11; 10(3):705-9. PubMed ID: 12684647 [Abstract] [Full Text] [Related]
10. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. Eguchi R, Fujimori Y, Takeda H, Tabata C, Ohta T, Kuribayashi K, Fukuoka K, Nakano T. J Cell Physiol; 2011 Mar 11; 226(3):762-8. PubMed ID: 20799280 [Abstract] [Full Text] [Related]
12. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Freitas RA, Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, Lucena-Araujo AR, Lima AS, Abreu e Lima RS, Garcia AB, Jordão AA, Falcão RP, Vannucchi H, Rego EM. Leuk Res; 2009 Jul 11; 33(7):958-63. PubMed ID: 19013639 [Abstract] [Full Text] [Related]
13. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T. Leukemia; 2000 Oct 11; 14(10):1743-50. PubMed ID: 11021749 [Abstract] [Full Text] [Related]
14. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. Ramos AM, Fernandez C, Amrán D, Esteban D, de Blas E, Palacios MA, Aller P. J Cell Physiol; 2006 Dec 11; 209(3):1006-15. PubMed ID: 16972261 [Abstract] [Full Text] [Related]
15. Metabolism of arsenic trioxide in acute promyelocytic leukemia cells. Khaleghian A, Ghaffari SH, Ahmadian S, Alimoghaddam K, Ghavamzadeh A. J Cell Biochem; 2014 Oct 11; 115(10):1729-39. PubMed ID: 24819152 [Abstract] [Full Text] [Related]
16. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide. Wang X, Wang G, Dong D, Fu S, Yang B. Exp Toxicol Pathol; 2008 Sep 11; 60(6):481-8. PubMed ID: 18606528 [Abstract] [Full Text] [Related]
17. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Ramos AM, Aller P. Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480 [Abstract] [Full Text] [Related]
18. Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway. Zhao XY, He ZW, Wu D, Xu RZ. Chin Med J (Engl); 2007 May 05; 120(9):802-6. PubMed ID: 17531122 [Abstract] [Full Text] [Related]
19. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. Zhang P. J Biol Regul Homeost Agents; 1999 May 05; 13(4):195-200. PubMed ID: 10703942 [Abstract] [Full Text] [Related]
20. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells. Chen GQ, Zhou L, Styblo M, Walton F, Jing Y, Weinberg R, Chen Z, Waxman S. Cancer Res; 2003 Apr 15; 63(8):1853-9. PubMed ID: 12702573 [Abstract] [Full Text] [Related] Page: [Next] [New Search]